Media Advisory – Prime Minister’s itinerary for Sunday, May 26, 2024
OTTAWA, ON, May 25, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
NASA Launches Small Climate Satellite to Study Earth’s Poles
WASHINGTON, May 25, 2024 /PRNewswire/ — The first of a pair of climate satellites designed to study heat emissions at Earth’s poles for NASA is in orbit after lifting off atop Rocket Lab’s Electron rocket from the company’s Launch Complex 1 in Māhia, New Zealand at 7:41 p.
Statement by the Prime Minister on Africa Day
OTTAWA, ON, May 25, 2024 /CNW/ – The Prime Minister, Justin Trudeau, today issued the following statement on Africa Day: “Sixty-one years ago today, representatives of African countries founded the Organization of African Unity, now the African Union. On this anniversary, we join our par
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients
82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n=2/10) who received placebo, and patients treated with felzartamab showed reductions in disease-linked biomarkers and stabilization of eGFR 63% (n=7/11)
/R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Saturday, May 25, 2024/
OTTAWA, ON, May 24, 2024 /CNW/ – Note: All times local Greater Halifax Area, Nova Scotia 10:00 a.m. The Prime Minister will hold a roundtable with local community leaders. Note for media: Pooled photo opportunity This document is also available at https://pm.gc.ca SOURCE Prime Minister
PepsiCo Brands Lay’s® and Gatorade® Strengthen Commitment to Supporting Women in Sport in Celebration of UEFA Women’s Champions League Final
PepsiCo brands Lay’s® and Gatorade® unite in Bilbao, Spain, around the UEFA Women’s Champions League Final with programs that instill young female athletes with confidence and provide resources to fuel their participation in sport Lay’s RePlay unveils its 11th pitch in Bilbao, wi
Every vote counts: Manipal Hospital, Dwarka facilitates patient voting to strengthen democracy
NEW DELHI, May 25, 2024 /PRNewswire/ — Manipal Hospital took a significant step towards fostering civic responsibility by helping patients cast their votes in the Lok Sabha elections, ensuring they could exercise their right to vote. This effort underscores the hospital’s dedication to p
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3 Fabhalta showed a favorable safety profile with no new safety signals1 C3G, an ultra-rare
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company’s IgA nephropathy (IgAN) portfolio
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to ele
